Open access · US-GOV via ClinicalTrials.gov Clinical trial

Recurrent Neovascular Age-related Macular Degeneration After Discontinuation of VEGF Inhibitors Managed in a Treat and Extend Regimen

Authors not listed

St. Erik Eye Hospital · 2017

Disabled macroautophagy Human Randomized controlled trial

Abstract

The purpose of this study is to investigate prospectively the recurrence rate of active macular neovascularization (MNV) and the visual outcome in patients with nAMD previously on a Treat and Extend regimen where treatment has been discontinued due to disease stability.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-26 MST

Cite this

APA

Anonymous. (2017). Recurrent Neovascular Age-related Macular Degeneration After Discontinuation of VEGF Inhibitors Managed in a Treat and Extend Regimen. <em>St. Erik Eye Hospital</em>. https://clinicaltrials.gov/study/NCT04659512

Vancouver

Anonymous. Recurrent Neovascular Age-related Macular Degeneration After Discontinuation of VEGF Inhibitors Managed in a Treat and Extend Regimen. St. Erik Eye Hospital. 2017.

BibTeX

@misc{anon2017Recurr, title = {Recurrent Neovascular Age-related Macular Degeneration After Discontinuation of VEGF Inhibitors Managed in a Treat and Extend Regimen}, author = {Anonymous}, journal = {St. Erik Eye Hospital}, year = {2017}, }